Cymabay TherapeuEigentümerstruktur
| Preis (2024-03-22) | 52W Hoch | 52W Tief |
| 32.48 USD | 0 USD | 0 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 22,75 USD | 0 | 0 | 9 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 114.785.000 | 5,88 | 0,84 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Cymabay Therapeu
Mitarbeiter 101
Handelsplatz NASDAQ
Ticker Symbol CBAY
IPO Datum 2014-02-03
Adresse 7601 Dumbarton Circle, Fremont, CA, United States, 94555
Webseite https://www.cymabay.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Sujal A. Shah | President, CEO & Director |
| 2 | Dr. Charles A. McWherter Ph.D. | President of Research & Development and Chief Scientific Officer |
| 3 | Mr. Paul T. Quinlan | General Counsel, Chief Compliance Officer & Corporate Secretary |
| 4 | Mr. Harish Shantharam C.F.A. | CFO, Principal Accounting & Financial Officer |
| 5 | Mr. Ken Boehm | Senior Vice President of Human Resources |
| 6 | Mr. Patrick J. O'Mara | Senior Vice President of Business Development |
| 7 | Dr. Robert L. Martin | Senior Vice President of Manufacturing & Nonclinical Development |
| 8 | Ms. Klara A. Dickinson-Eason | Chief Regulatory & Quality Assurance Officer |
| 9 | Ms. Becki Filice | Senior Vice President of Portfolio & Product Leadership |
| 10 | Mr. Ben Kozub | Head of Commercial |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 2 | RA Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 3 | Franklin Resources Inc | 0,00% | 0,00 Mio. USD |
| 4 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 5 | State Street Corporation | 0,00% | 0,00 Mio. USD |
| 6 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 7 | Deutsche Bank AG | 0,00% | 0,00 Mio. USD |
| 8 | Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |
| 9 | Affinity Asset Advisors, LLC | 0,00% | 0,00 Mio. USD |
| 10 | Northern Trust Corp | 0,00% | 0,00 Mio. USD |
| 11 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 12 | Nuveen Asset Management, LLC | 0,00% | 0,00 Mio. USD |
| 13 | Amvescap Plc. | 0,00% | 0,00 Mio. USD |
| 14 | MPM Oncology Impact Management LP | 0,00% | 0,00 Mio. USD |
| 15 | Jefferies Financial Group Inc | 0,00% | 0,00 Mio. USD |
| 16 | Bank of New York Mellon Corp | 0,00% | 0,00 Mio. USD |
| 17 | Artal Group S A | 0,00% | 0,00 Mio. USD |
| 18 | Wellington Management Company LLP | 0,00% | 0,00 Mio. USD |
| 19 | JANE STREET GROUP, LLC | 0,00% | 0,00 Mio. USD |
| 20 | Barclays PLC | 0,00% | 0,00 Mio. USD |